IBA receives FDA approval for its proton therapy specific Cone Beam CT (CBCT) system and announces strategic alliance with Philips
IBA (Ion Beam Applications SA), the world’s leading provider of proton therapy solutions for the treatment of cancer recently announced that it had received combined clearances from the U.S. Food and Drug Administration (FDA) that will enable IBA to market-launch the proton therapy specific Cone Beam Computed Tomography (CBCT) system. IBA has received clearance from […]
